<SEC-DOCUMENT>0001213900-25-120354.txt : 20251211
<SEC-HEADER>0001213900-25-120354.hdr.sgml : 20251211
<ACCEPTANCE-DATETIME>20251211080528
ACCESSION NUMBER:		0001213900-25-120354
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20251211
DATE AS OF CHANGE:		20251211

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-60249
		FILM NUMBER:		251563555

	BUSINESS ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
		BUSINESS PHONE:		(561) 426-4444

	MAIL ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Silvercape Investments Ltd
		CENTRAL INDEX KEY:			0002059711
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		80 ROBINSON ROAD, #13-03
		CITY:			SINGAPORE
		STATE:			IN
		ZIP:			068898
		BUSINESS PHONE:		6597256448

	MAIL ADDRESS:	
		STREET 1:		FOURTH FLOOR, ONE CAPITAL PLACE
		STREET 2:		P.O. BOX 847
		CITY:			GRAND CAYMAN
		STATE:			CA
		ZIP:			KY1-1103
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Silvercape Investments Ltd -->
          <cik>0002059711</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, $.001 Par Value</securitiesClassTitle>
      <dateOfEvent>12/09/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001040130</issuerCIK>
        <issuerCUSIP>716382106</issuerCUSIP>
        <issuerName>PETMED EXPRESS INC</issuerName>
        <address>
          <com:street1>420 South Congress Avenue</com:street1>
          <com:city>Delray Beach</com:city>
          <com:stateOrCountry>FL</com:stateOrCountry>
          <com:zipCode>33445</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Michael Penney</personName>
          <personPhoneNum>(212) 836-8000</personPhoneNum>
          <personAddress>
            <com:street1>Arnold &amp; Porter Kaye Scholer LLP</com:street1>
            <com:street2>250 W. 55th Street</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10019</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0002059711</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>SilverCape Investments Limited</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>2579696.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2579696.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>2579696.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>12.28</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>(1) The percent of class represented is based on 21,015,559 shares of Common Stock outstanding as of September 30, 2025, as last reported by the Issuer in its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Peter Kennedy</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2579696.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2579696.00</sharedDispositivePower>
        <aggregateAmountOwned>2579696.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>12.28</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>(1) Peter Kennedy, the managing director of SilverCape Investments Limited ("SilverCape"), has voting and investment power with respect to the Common Stock held by SilverCape. Mr. Kennedy disclaims any beneficial ownership of the Common Stock beneficially owned by SilverCape.

(2) The percent of class represented is based on 21,015,559 shares of Common Stock outstanding as of September 30, 2025, as last reported by the Issuer in its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, $.001 Par Value</securityTitle>
        <issuerName>PETMED EXPRESS INC</issuerName>
        <issuerPrincipalAddress>
          <com:street1>420 South Congress Avenue</com:street1>
          <com:city>Delray Beach</com:city>
          <com:stateOrCountry>FL</com:stateOrCountry>
          <com:zipCode>33445</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>Explanatory Note: This Amendment No. 1 to Schedule 13D ("Amendment No. 1") is being filed jointly by SilverCape Investments Limited ("SilverCape") and Peter Kennedy ("Kennedy" and together with SilverCape, collectively, the "Reporting Persons") to amend and supplement the Statement on Schedule 13D filed by the Reporting Persons with the Securities and Exchange Commission on May 20, 2025 (the "Prior Statement" and as amended by this Amendment No. 1, this "Schedule 13D") with respect to shares of common stock, par value $.001 per share (the "Common Stock"), of PetMed Express, Inc., a Florida corporation (the "Issuer"). Except as amended and supplemented by this Amendment No. 1, the Prior Statement remains in full force and effect.</commentText>
      </item1>
      <item2>
        <filingPersonName>Item 2 of the Prior Statement is not being amended by this Amendment No. 1.</filingPersonName>
        <principalBusinessAddress>Item 2 of the Prior Statement is not being amended by this Amendment No. 1.</principalBusinessAddress>
        <principalJob>Item 2 of the Prior Statement is not being amended by this Amendment No. 1.</principalJob>
        <hasBeenConvicted>Item 2 of the Prior Statement is not being amended by this Amendment No. 1.</hasBeenConvicted>
        <convictionDescription>Item 2 of the Prior Statement is not being amended by this Amendment No. 1.</convictionDescription>
        <citizenship>Item 2 of the Prior Statement is not being amended by this Amendment No. 1.</citizenship>
      </item2>
      <item3>
        <fundsSource>Item 3 of the Prior Statement is hereby amended and restated in its entirety as follows:

The Reporting Persons purchased the shares of Common Stock covered by this Amendment No. 1 in open market purchases for an aggregate purchase price of $11,228,622. The source of the Reporting Persons' payment of the purchase price for each purchase of shares of Common Stock covered by this Schedule 13D was working capital of SilverCape.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>Item 4 of the Prior Statement is hereby amended and supplemented to add the following:

On December 10, 2025, SilverCape sent a Letter re: Non-Binding Proposal for Potential Transaction (the "Letter") to the Issuer providing a non-binding proposal (the "Proposal") to take the Issuer private by acquiring 100% of the Issuer's outstanding Common Stock at a price of $4.00 per share of Common Stock in cash (the "Potential Transaction"). The Proposal states that the purchase price for the Potential Transaction would be funded with SilverCape's cash on hand and that the Potential Transaction would not be subject to any financing conditions or contingencies.

The Proposal for the Potential Transaction was (and remains) non-binding and is subject in all respects to, among other things: (a) the Reporting Persons' further due diligence (including, but not limited to, financial, tax, accounting, legal, compliance, human resources, IT and regulatory due diligence) and (b) the execution of a mutually acceptable definitive agreement with terms and conditions customary for transactions of the type contemplated by the Proposal (the "Definitive Agreement"), including, without limitation, that the Issuer and its board of directors take all actions necessary to render inapplicable the Issuer's shareholder rights plan or other similar antitakeover protections that are or could become applicable in connection with the transactions contemplated by the Letter, the Potential Transaction or the Definitive Agreement.

As provided in the Letter, the Reporting Persons are seeking to commence due diligence and the preparation of the Definitive Agreement as soon as possible.

The foregoing description of the Letter is not intended to be complete and is qualified in its entirety by reference to the full text of the Letter, which is filed as Exhibit 99.2 to this Amendment No. 1 and is incorporated herein by reference.

There can be no assurance that a Definitive Agreement with respect to the Potential Transaction will be executed or, if executed, whether the Potential Transaction will be consummated. No legally binding obligation with respect to the Proposal or the Potential Transaction will arise until such time, if ever, as a binding Definitive Agreement has been executed by the relevant parties. There is also no certainty as to whether, or when, the Issuer may respond to the Letter, or as to the time table for execution of any Definitive Agreement. The Reporting Persons reserves the right to modify or withdraw the Proposal at any time and to cease discussions and negotiations at any time. Neither the Letter nor this Schedule 13D is meant to be an offer to purchase or a solicitation of any offer to sell shares of the Issuer's Common Stock or other securities.

The Reporting Persons intend to engage in discussions with the Issuer regarding the Potential Transaction. The Reporting Persons may change the terms of the Proposal or the Potential Transaction, determine to accelerate or terminate discussions with the Issuer with respect to the Potential Transaction, withdraw the Proposal described in the Letter or any other proposal with respect to the Potential Transaction, take any action to facilitate or increase the likelihood of consummation of the Potential Transaction, or change their intentions with respect to any such matters, in each case at any time and without prior notice. The Reporting Persons reserve the right to, directly or indirectly, take such additional steps as they may deem appropriate to further the Potential Transaction or otherwise to support their investment in the Issuer, including, without limitation: (a) engaging in discussions with other shareholders, advisors and other relevant parties; and (b) entering into confidentiality arrangements, and other agreements, arrangements and understandings in connection with the Potential Transaction.

The Potential Transaction may result in one or more of the actions specified in clauses (a) to (j) of Item 4 of Schedule 13D, including, without limitation, the acquisition of additional securities of the Issuer, a merger or other extraordinary transaction involving the Issuer, the delisting of the Common Stock from the Nasdaq and the Common Stock becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended.

The Reporting Persons intend to review their existing investment in the Issuer on a continuing basis. Depending on the Reporting Persons' evaluation of various factors, including, without limitation, the outcome of any discussions referenced above, the Company's financial position, results and strategic direction, actions taken by the Company's management and the Board, price levels of the Common Stock and other investment opportunities available to the Reporting Persons, compliance with applicable laws, general market and economic conditions, ongoing evaluation of the Issuer's business, financial condition, operations and prospects, the relative attractiveness of alternative business and investment opportunities, the Reporting Persons' need for liquidity, and other future developments, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate, including, without limitation, acquiring shares of Common Stock and/or other equity or other securities of the Company or disposing of some or all of the securities beneficially owned by the Reporting Persons in public market or privately negotiated transactions, formulating other plans or proposals regarding the Issuer or its securities to the extent deemed advisable by the Reporting Persons, and/or otherwise changing their intention with respect to any and all matters referred to in Item 4 of this Schedule 13D.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>Item 5(a) of the Prior Statement is hereby amended and restated in its entirety as follows.

As of the filing date of this Amendment No. 1, SilverCape is the holder of record of 2,579,696 shares of Common Stock, representing approximately 12.28% of the shares of Common Stock. The percentages used in this Amendment No. 1 are calculated based on 21,015,559 shares of Common Stock outstanding as of September 30, 2025, as last reported by the Issuer in its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.

Kennedy, as the managing director of SilverCape, has voting and investment power with respect to the Common Stock held by SilverCape. Kennedy disclaims any beneficial ownership of the Common Stock beneficially owned by SilverCape.</percentageOfClassSecurities>
        <numberOfShares>Item 5(b) is not being amended by this Amendment No. 1.</numberOfShares>
        <transactionDesc>Item 5(c) is not being amended by this Amendment No. 1.</transactionDesc>
        <listOfShareholders>Item 5(d) is not being amended by this Amendment No. 1.</listOfShareholders>
        <date5PercentOwnership>Item 5(e) is not being amended by this Amendment No. 1.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>tem 6 of the Prior Statement is hereby amended and restated as follows:

The information set forth in Item 4 of this Amendment No. 1 is incorporated herein by reference. On December 9, 2025, the Reporting Persons submitted the Letter to the Issuer's board of directors. The Letter is attached hereto as Exhibit 99.2 and incorporated herein by reference.

Except as otherwise described in the Prior Statement, this Amendment No. 1, the Joint Filing Agreement attached hereto as Exhibit 99.1 and the Letter attached hereto as Exhibit 99.2, (i) there are no contracts, arrangements, understandings, or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any person with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Item 7 of the Prior Statement is hereby amended and restated in its entirety as follows:

99.1  Joint Filing Agreement, dated as of May 20, 2025 (incorporated by reference to Exhibit 1 to the Prior Statement filed by the Reporting Persons on May 20, 2025).

99.2  Letter re: Non-Binding Proposal for Potential Transaction, dated December 9, 2025.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>SilverCape Investments Limited</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Peter Kennedy</signature>
          <title>Managing Director</title>
          <date>12/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Peter Kennedy</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Peter Kennedy</signature>
          <title>Managing Director</title>
          <date>12/11/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>2
<FILENAME>ea026919701ex99-2_silvercape.htm
<DESCRIPTION>LETTER RE: NON-BINDING PROPOSAL FOR POTENTIAL TRANSACTION, DATED DECEMBER 9, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; width: 50%; font-size: 10pt; text-align: left"><IMG SRC="ex99-2_001.jpg" ALT=""></TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="background-color: white">c/o 80 Robinson
    Road, #13-03</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="background-color: white">Singapore
    068898</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">TR-413365</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">www.silverCape.com</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">December 10, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VIA E-MAIL:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PetMed Express, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">420 South Congress Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Delray Beach, FL 33445</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re:&nbsp;<U>Non-Binding Proposal for Potential Transaction</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Members of the Board of Directors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SilverCape Investments Limited (&ldquo;<U>we</U>&rdquo;, &ldquo;<U>us</U>&rdquo;,
&ldquo;<U>our</U>&rdquo; and <U>SilverCape</U>&rdquo;) is pleased to submit the following preliminary, non-binding proposal (the &ldquo;<U>Proposal</U>&rdquo;)
to PetMed Express, Inc. (the &ldquo;<U>Company</U>&rdquo;) to acquire 100% of the outstanding equity interests of the Company on the terms
summarized below (the &ldquo;<U>Potential Transaction</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. <U>Price Per Share</U>.
We believe the Company would be best positioned as a private company, and we are prepared to attribute significant value to the Company&rsquo;s
brand and licenses, and to work with the current leadership team to execute on a transaction to leverage these assets. Specifically, SilverCape
would like to discuss our Proposal for a Potential Transaction with the Company&rsquo;s board of directors and management that would take
the Company private at a price of $4.00 per outstanding share of common stock in cash. Our Proposal reflects a significant premium relative
to the current market price of the Company&rsquo;s common stock, and we believe our Proposal also reflects the value of the Company&rsquo;s
business and its long-term potential.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2. <U>No Financing Contingency</U>.
The purchase price for the Potential Transaction would be funded with cash on hand at SilverCape, and the Potential Transaction would
not be subject to any financing conditions or contingencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3. <U>Transaction Structure</U>.
We propose to acquire 100% of the Company&rsquo;s outstanding common stock, with the Company becoming a direct or indirect wholly-owned
subsidiary of SilverCape. The specific structure for the Potential Transaction is subject to our further analysis and due diligence, and
we look forward to an open discussion with the Company regarding the transaction structure and the preparation of the Definitive Agreement
(as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. <U>Contingencies and Conditions</U>.
Our Proposal for the Potential Transaction is subject in all respects to: (a) our further due diligence (including, but not limited to,
financial, tax, accounting, legal, compliance, human resources, IT and regulatory due diligence) and (b) the execution of a mutually acceptable
definitive agreement with terms and conditions customary for transactions of this type (the &ldquo;<U>Definitive Agreement</U>&rdquo;).
Additionally, the Definitive Agreement for the Potential Transaction will include customary closing conditions for transactions of this
type, including, without limitation, that the Company and its board of directors taking all necessary action to render inapplicable the
Company&rsquo;s shareholder rights plan or other similar antitakeover protections that are or could become applicable in connection with
the transactions contemplated by this Proposal, the Potential Transaction or the Definitive Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex99-2_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5. <U>Timing</U>. We believe
the timing of the Potential Transaction is critical to preserving value for the Company&rsquo;s stockholders, and we look forward to commencing
our due diligence and preparation of the Definitive Agreement as soon as possible. We have engaged external legal counsel, and they are
prepared to move expeditiously and to engage with the Company and its legal counsel and other advisors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Proposal is intended to serve as an outline of the basic terms
of a Potential Transaction and to provide a basis for further discussions, and this Proposal is not a summary of all matters that would
be contained in the Definitive Agreement. This letter and the Proposal are not intended to constitute an offer capable of acceptance,
and this Proposal does not constitute a legally binding commitment or agreement to consummate the Potential Transaction (or any other
transaction) and does not create any obligation or liability binding on SilverCape or its affiliates with respect to the Potential Transaction
or otherwise. This Proposal is neither an offer to purchase nor a solicitation of an offer to sell shares of the Company&rsquo;s common
stock or other securities. We shall not be legally bound or subject to any obligations with respect to this Proposal, the Potential Transaction
or otherwise until such time, if ever, as a binding Definitive Agreement providing for the consummation of the Potential Transaction has
been executed by us and the Company. We reserve the right to modify or withdraw this Proposal at any time and to cease discussions and
negotiations at any time, in all cases, without incurring any liability to the Company or its affiliates, employees, officers, directors,
advisors or shareholders. Each party will bear its own transaction-related expenses, including, without limitation, investment banking,
legal, tax and accounting expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please note that we will be filing an amended Schedule 13D as a result
of this Proposal, and this letter will be included as an exhibit to such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We request that you keep any discussions relating to this letter and
the Proposal and the Potential Transaction strictly confidential (except as required by law and for the sharing of information with the
Company&rsquo;s advisors and employees who have a need to know such information for purposes of the Company&rsquo;s consideration of this
Proposal and the Potential Transaction). Disclosure by the Company or any of its directors, employees or advisors of the content of any
discussions or negotiations related to this letter and the Proposal and the Potential Transaction, or any other leaks, prior to execution
of the Definitive Agreement may result in our withdrawing our interest in the Proposal and the Potential Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SilverCape is excited to engage constructively with the Company, its
management and board of directors, and its advisors to deliver a transaction that maximizes value for the Company&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please contact me to discuss next steps.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; font-size: 10pt">Very truly yours,</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">/s/ Peter Kennedy</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Peter Kennedy</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Managing Director</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><I>Page 2</I></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  G -H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^\B3Q7X7C
M\0P>$&\0:4/%-SIMWK]OX?\ MUL=8ET6POK?3[S4TT[S/M3:?!J%Q!8378B\
MA+QVMR_G1RQK_/Q_P6G_ ."EGQ)_8Z\=_L]_##X.+>:?XDFUJR^+_C_4KFSG
MATOQ'X)\-:LFG3> UN9XXX+G_A)A+-!?&"XD%K%'!)<"$2122_E/^W)^UE^T
MQ^RK_P %DM8^.7C^*XCA^'6JZ#H7@WPKIUS<?V-XB_9D\0(DE]H5B?,FTZ:\
MUP-=ZYJ$S.)M/\<VUXLT5LX@B;]P?^"I?[-_@O\ X*'?L,Z1\=/@[=:3K/C/
MP)X*E^-7P;\8#4+#3K?6_"5WH,-_XC\(:CKE_-;0V+:OHLMW-:#5Y+:WTKQ#
MID,6KG3#'>R#]^R#@#(O#[B?P@SWCJOA\ZX+X_RS'4H8["U88G"X/%XJ%7"X
MF#K0C4H5,5ESKPG.FFYTZD91G34J*1_/.=<<9QQWPYXH9-PO0EEG$W!N;X&?
MU/%2EA:V:83!5J>(Y??E2JPH8M8>5.56\8>SE%^T2E%ON_VI?^"MWP@^ _[&
M?PH_:L\!Z=;_ !(U'X[+HZ?"CP#'K<6E7EY-,D=SXS_MK48+#5'MX_!OEZC%
MK[6ME<-)J$&GVD$8DNEN!J_\$M?^"@OQG_X*!:5XU\<>*?@!H7PE^&GA/4%T
M#1/$UEX^U+Q+/XK\2B#S]0CL+2[\(Z'#-I=K!(-\\-P5M[D&)WDF4QCXK_8T
M_91_X)?>!/V7/A!X'_:>^*7[*OQ:^*.DV6L^+M:/C#XR>!]2M_!'B?QS/I?B
M/Q1X:\.Z>GC".QLK#2KRUT^/5'T]/(NKNUN9HIY[2YWG]FOV8];_ &0M"T.S
M^#?[)WB_X*7'ASP7%=ZG_P ('\(O&GA?Q N@6NK2-/-?ZIINAZOJ=Y9B_O)S
M):W-\(Q<HW^CL\<3*GA<5O@;(>'N),AR;A'/,YS9<2599?XAYOE^99+2P63N
MLXT\OH8*K0IT<6JU)PIT<75GSU9*55)^T@G[W#%?C#..*,CSO->*,HRG+:?#
MM+"8W@O+<=A,TK5LRE0C%U*OLZM6I1BYW<JMDX*R333:^M)"%7<QPJ@Y(!8D
MG  55!9F8X"JH+,2%4$D _/7[1/[4_[.?[)_@.Z^)?[27QB\!?!WP3:O/#'K
M/CG6+?3AJ=U:Q)/<6.@Z86;5/$FH11LK/8Z%9ZA=1')>$&-POT).Q2)W D8H
M-X6)2[OM(;RU4*YS)C82J[E#%E*L P_RK_\ @LY\9O%7[:W_  6H^*'P>^/'
MQ77X;?"7X9?M&Z+^S#X4U;Q"9]6\'?!WX>Z;<Z9I6L>/9/#+7UI;6FJZEJ=S
MJ7B?_A((V6]>WO=MY%+:VMU&/R3"X=5E*]E)*Z3MS-](Q3Z_C?3<_7Z\W!IM
MI*+3=]K)IW;/[E?"_P#P<7?\$>?%'B2+PW;?M>^&K"XFNWL[?5M6\(^.K#0&
ME10=YUA_#!M[>!WDBA$\[)#'),BSRQ 2,GZS6GQX^#6I_"6]^/&A_$SP;XC^
M#EAX0UKQ]/\ $CPMKEGXI\)MX.\.:?<:IKNOVFJ>'I-2AU"RTJQM;B2\^P&Y
MFBEB:U,1NL0'^2CQI_P:4_L'_%/X&KJG[,O[4?Q7E^(U]IB3:-\6/$7B?P3\
M7OA5XJU$VNR:XET33M"E@MM#U"Y$.IVIT#Q3<2Z;<K:&1[OR'M9OHC_@DA_P
M2=^+O_!-K]@_]MJ#]M+XO>*9K/XO?#?XOVOB?X)_#?Q+'XH\ ?#?P+I'@?Q#
MI^L^,_!LFI)(^O?$WQGX6AN-:B9+?1](T>)DT.72[C$EY!;HQOO9W2Y7HVW:
MRL[.[NOO)6(;3:U23;:U22W=TK65GJ?L]^S'_P %6?\ @GQ^V9\1KKX1_LP_
MM0> _C#\1K+P[JGBVZ\+>&[#Q=;WL/AS1;O3+'4]6:?6O#FE6!MK6ZUC3HV"
MW9ED$[2PQR16]R\.-X7_ ."OG_!-OQG^T'%^RKX7_:T^'.M_M!S_ ! UCX61
M?#"RL_%[Z[)X^T#5-1T75_#J7#^&TT@SV>I:3J%N]Y_:7]FR+;-<07LMJ\<S
M_P O/_!N3H'_  24B_;LUZ7]AWQ-^VIJ_P 7K;]GCQM#J=K^T#X>\!:%X(3P
MD_BCP0E_?V%YX0D_M236C=)'"+>X>&W9)$="^UZ_'']D-RG_  <KZ&%+A?\
MAY;\88'199X0T8^)_P 1R#Y<3N9R#AE,]RFQ@)&$@4QNW0^-)7E&+DTM6K)O
M57\@6(UBY.T9-)-Z+5I;M6/]3%;F!PA60%9(UD1\,$9'.U<.0$+,>!'N\S_9
MJ1G50"Q//0!6+-P3A5 +,P )*@%@ 20 ":_GX^&7_!Q=^Q3\0OVT-,_87O?!
M7QZ\!_&G5/B_J_P363Q?X0TZU\+V7C[3=1O](LK2\U27Q!)=:?:ZY/:"#3[E
M]+:U:>^L/.E@M[G[8?T5_P""A'_!0?X$_P#!-;X"+^T%\>X_$]WX6O?&WA[P
M3I.@^"]/M]9\5:]K_B.6:2)-+TF\GLS/)IVF6&IZW>(LBK%:Z9+$ADOKBQM+
MK!TYIV<))]G%I_D="J4WM.#])+_,^\U='SM8-M.& ()4]=K#JK#NI ([BAG5
M1D[B,@?*CN<D@<JBLPY/)(P!R< $U^27[,7_  6._9%_:/\ V.OB)^W;J%_X
MH^"7[-WPX\6ZYX3U7QE\:]/T_P .'6-4\/PV<MTOAO3=.GO;KQ!<75QJ-EIV
MF6M@ES)J6JO-8Z<+N_TZ_M[;\HM?_P"#OG_@GMI?CF;PWI?PF_:0\4^$X[AC
M'XYM/"_ANTBO=,$B1?VWH_A2_P!8M/%-WI96>"Y2:?3X9+FRE6>S2X+1QRGL
MZG\D_P#P%_Y![2G_ #P_\"7^9_6471<;F5<E0-Q"Y+$*H&<<LQ"@=2Q '-,,
MR#KO'W0 8I<DMT"C9EB "6"@E%!9L*"1\,_ G_@HG^RS^TW^RMXJ_:]^ GCZ
M#XD_"?P1X5\8>*/%%OI$(M_&/A^;P/H=]KVL^'-8\+W?DWNE>(UM;"5K'3=3
MBM6OE:"[L6NK:6&5_P A_A-_P=2?\$O?B-%\0[W6[GXL_"?1O '@9?'ES?\
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M9I??VQ%9S6^@>$=$TG27TN6;5+E-/N.BEA5*G.I6?LG"+DE/W7=*ZW5]]/\
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MGART$.F_8M)BN+7PGX9TF::RMM1DTO0]-=U/VS8)+FXW@,R)7\R"_P#!>_\
MX*7.AWZW\+$?B.!9_@VR[IG_ '=NAF:^ CW3,JJ7=4#$;R%)-?T-?\$;_P!H
M_P#;5_:[\#>+?CM^TW?^$;;X?7VJ-X:^%&C>'O ;>%M2U233HF;Q!XFU2:>^
MEO(;5+M6TVT@GLX(KMY/M%MOB"RO[OCE@_I!X?@W'TO$?B_@&IP]+%Y-+!X'
MA[&.>:9C['V;A1G1HX&,IQ2BU5BY4Z47%NO-*#OYOA/B_!JKQBZG W#_ !<L
M[G2E#$XG/,3CEE^%4G%5*E'ZS4=*I5@W>$6N:5N6FM;'[:73!8)&(=@JAC'&
M(V>;!!^SHLI$;-<8\@*S+N,FT,I(8?RD_P#!7?\ X-NO G_!0+XS^+OVB_V=
M/C;H?P7_ &A_$%GIEQ\5?!'BG3U\3?"_QE?PZ;'I>A^([S3-/63Q!X!UW5=+
ML;B.ZU>WMM5BU8">.2)[47D]?U97ZW36=PMB\,5X8R+:6X$KP0S$CRYI8H"L
MMPD38D:U22+[6%^S&:%93*G^:K^V(O\ P7Q_X)<?M\?%S]LGQ'J7Q%\;7?Q$
MURXM]0^+?@CP7JOQ3_9N^(OP]@U"Y/ACP9J7@BTEO(O 6A>&;&ZL=-T+PWJU
MGHNK:5?33:I;WDMREJD_\@4'JTJD:;>B<FDDVFDVVU9)]>GY_P!55T[WY)3B
MM7%1;YDK75DG>]K6/G'XQ?\ !('_ (+5?\$M=#UOXX>"[OQAX?\  G@RU35-
M<^+/[*'QVU5-.T.PM+N&%-5\5:#;S>%];C\)V[SQRZG&?!U]I#6)N8==DDT3
M^TG7]P_^".7_  61^/O[<O[*7[>7[*?[5FLGQU\2?AE^QO\ &KXE?#SXMSZ;
M9>'O$7B_P/<>!=5T?4?#OQ!T[1[/2]#O_%6FW6H6.JZ3K6E:19/<:(;M;VXN
MYQ(S?E;^T3_P<H_\%+?VS/@IXT_9:\/_ +/WPW\'7GQ<\,:IX"\9Z]\)O!WQ
M7\6_$#7O#?BJT.C^(O#NG:+J]SKUMH$?B+3I[O2]1M[. 74=C>W<5E'$[ ']
M2?\ @B=_P2'^-?[&G[&W[>_[67[2_A#4/A]\3/C'^QY\4_A[\*_@_JT;W?CK
MPO\ #R'P!K^N:EKOBG3[>2\N;/7?%&L)I^G:-HS*FLVNFV4EK>V%M)=VL4O8
MJE**Y:LHU)W7+.,E*SYHVDWLDG=ORN]]N.I2JSC*5.,J<%%N491<6TD[Q2LF
MVUI;KL?FG_P:*LK?\%.O&95"F/V3OB!G]Z[ _P#%<^ ^H/!Y/?&.HKY[_9#V
M?\1+.BAPQ5_^"EWQHC&W?N#R?$GXE1QLI0%E9)&5E<X1" \C*BLP^GO^#2;P
MOXKT+_@IEXVN]=\)>+=#LD_96^(EHU_K/A?7]*T];N'Q[X%22T;4-0TZWLA=
M QR$6QG$[I&\B1M&I8>!?LC^$/&MM_P<F:'JMQX(\=6FF_\ #R/XV:E'J5SX
M*\3VMA/86_Q(^),CW4-_<Z5%9R6,R !;\3_8C%*MQ]H\C][41J1C4Q$E*/\
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M&^!CO="\6^'Y9MT4'B'PMK%O9:YHTDVV$ZCIUJMPRP;WK_-%O?AC_P %8O\
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M8TG3==LIM-U?3;#5=.ND$5YI^I6T%Y8W4096,=Q:W,4T$R94,L<D;+O53E2
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M&M-2MY['4[&RU*PNI"UU97MO#<6EPI4@//#<17,<LP=4D'EPVJ G[S; &**
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0QSY))/[U>IY/_+2BB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-2_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  6 'P# 2(  A$! Q$!_\0
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M:A:NT86XL;ZWN;*[A+074,T$DD3%%>IPYQCQAD57,,JR'BOB/(LMK8?):=;
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62DES-NVBOT6YE5BHS2227)?3_$?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
